Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Peter Mol is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
Desmet, T., Julian, E., Van Dyck, W., Huys, I., Simoens, S., Giuliani, R., Toumi, M., Dierks, C., Dierks, J., Cardone, A., Houÿez, F., Pavlovic, M., Berntgen, M., Mol, P., Schiel, A., Goettsch, W., Gianfrate, F., Capri, S., Ryan, J. & Ducournau, P. & 2 others, , 2024, In: Journal of Market Access and Health Policy. 12, 1, p. 21-34 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)5 Downloads (Pure) -
Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”
de Vries, S. T., Al-Mugoter, N. H. S., Petkoska, I., Verweij, S., Elferink, A. J. A. & Mol, P. G. M., Jan-2024, In: Applied Health Economics and Health Policy. 22, 1, p. 123-124 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open AccessFile24 Downloads (Pure) -
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Verweij, S., Ahmed, W., Zhou, G., Mavridis, D., Nikolakopoulos, S., Elferink, A. J., Rengerink, K. O., Bijlsma, M. J., Mol, P. G. M. & Hak, E., May-2024, In: Pharmacoepidemiology and Drug Safety. 33, 5, 12 p., e5810.Research output: Contribution to journal › Review article › peer-review
Open AccessFile41 Downloads (Pure) -
Eligibility for omecamtiv mecarbil in a realworld heart failure population: Data from the Swedish Heart Failure Registry
Lindberg, F., Øigaard, N., Metra, M., Rosano, G. M. C., Dahlström, U., Mol, P., Hage, C., Lund, L. H. & Savarese, G., 24-May-2024, In: PLoS ONE. 19, 5 , 20 p., e0303348.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure) -
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries
Wallner, M., Biber, M. E., Stolfo, D., Sinagra, G., Benson, L., Dahlström, U., Gudbjörnsdottir, S., Cosentino, F., Mol, P. G. M., Rosano, G. M. C., Butler, J., Metra, M., Lund, L. H., Ferrannini, G. & Savarese, G., 1-Jul-2024, In: European Heart Journal - Cardiovascular Pharmacotherapy. 10, 4, p. 296-306 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure)
Activities
-
PhD project in the IMI European Platform for Neurodegenerative Diseases EPND project
Mol, P. (Other)
2022 → 2027Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Drug, Regulation, science, collaborate to improve drug development and evaluation
Mol, P. (Speaker)
Nov-2022Activity: Talk and presentation › Inaugural lecture › Popular
-
International Journal of clinical Pharmacology and Therapeutics (Journal)
Mol, P. (Editorial board member)
2022 → …Activity: Peer-review and editorial work › Editorial work › Professional
-
HTx project meeting (Barcelona, Spain)
Mol, P. (Other)
Oct-2022Activity: Other › Other research activities › Professional
-
38th ICPE International Conference on Pharmacoepidemiology
Mol, P. (Organiser)
Aug-2022Activity: Organising and attending an event › Organising and contributing to an event › Academic
Press/Media
-
Towards a more efficient use of registry-based real-world data in Europe: the More-EUROPA project
06/02/2024
1 Media contribution
Press/Media: Public Engagement Activities › Professional
-
Peter Mol en Patrick Vrijlandt namens Nederland in het Europese CHMP
30/08/2023
1 item of Media coverage
Press/Media: Other › Professional
-
Oratie Peter Mol over kennisuitwisseling tussen wetenschap en medicijnautoriteit
15/11/2022
1 Media contribution
Press/Media: Expert Comment › Popular
Prizes
-
Among the most popular scientific papers in Drug Safety 2019
Vries, de, S. (Recipient), Mol, P. (Recipient) & Denig, P. (Recipient), 2019
Prize: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
Vries, de, S. (Recipient), Denig, P. (Recipient), Mol, P. (Recipient) & Puijenbroek, van, E. (Recipient), 30-Apr-2019
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
Vries, de, S. (Recipient), Mol, P. (Recipient) & Denig, P. (Recipient), 2018
Prize: Other distinction › Academic
-
Among the most popular publications in Drug Safety in 2017
Vries, de, S. (Recipient) & Mol, P. (Recipient), 2017
Prize: Other distinction › Academic